Carcinoembryonic antigen, monoclonal, by IHC

Alphabetical Test listing

Carcinoembryonic antigen, monoclonal, by IHC-12376 - Technical only, 12379 - Technical & interpretation

  
Carcinoembryonic antigen, monoclonal, by IHC
  
12376 - Technical only, 12379 - Technical & interpretation
  
LAB12376
LAB12379
  
CEA, monoclonal
  
  • All IHC stains will include a positive control tissue
  
  • 95% of adenocarcinomas of colon, lung, breast, pancreas, biliary tract are CEA positive
  • Renal cell, prostatic, hepatocellular, adrenocortical, and thyroid carcinomas as well as mesotheliomas are usually negative for CEA
    NOTE: When CEA is ordered, the monoclonal CEA will be automatically performed unless the polyclonal antibody is specifically requested. Polyclonal CEA also reacts with NCA (nonspecific cross reacting antigens) and BGP (biliary glycoproteins). It is the unique CEA/BGP expression that is useful in identifying hepatocellular carcinomas (see section on immunohistochemistry panels). Thus, if the hepatocellular carcinoma panel is requested, then both monoclonal and polyclonal CEA will be automatically performed.
  
Tissue
  

Prepare a formalin-fixed, paraffin-embedded (FFPE) tissue block

  

Formalin-fixed, paraffin embedded (FFPE) tissue block

  

FFPE tissue section mounted on a charged, unstained slide

  

Ambient (preferred)

  
  • Unlabeled/mislabeled block
  • Insufficient tissue
  • Slides broken beyond repair
  
AHL - Immunohistochemistry
  
Mo - Fr
  
1 - 2 days
  

Immunohistochemical staining and microscopic examination

  

If requested, an interpretive report will be provided

  

Specifications

  • CEA is a family of HMW glycoproteins
  • Expression of CEA by tumor is often proportional to degree of differentiation
  • CEA also labels PMNs

Staining pattern

  • Cytoplasmic and apical based staining

  
88342 - 1st stain
88341 - each additional stain
  
06/19/2017
  
10/17/2018